Allergy, Asthma and Clinical Immunology

Medicine & Life Sciences

1. Eosinophils 100%
2. Asthma 66%
3. T-Lymphocytes 52%
4. Dendritic Cells 42%
5. Interleukin-33 31%
6. Inflammation 26%
7. Interleukin-5 23%
8. Eosinophilic Esophagitis 23%
9. Eosinophil Peroxidase 22%
10. Alternaria 22%
11. Allergens 21%
12. Eosinophilia 19%
13. Lung 18%
14. Regulatory T-Lymphocytes 18%
15. Neoplasms 18%
16. Eosinophil-Derived Neurotoxin 18%
17. Cytokines 16%
18. B-Lymphocytes 14%
19. Vaccines 14%
20. Catenins 14%
21. Interleukin-10 13%
22. Proteins 13%
23. Adrenal Cortex Hormones 13%
24. Immunotherapy 13%
25. Ovarian Neoplasms 13%
26. Antigens 13%
27. Immunity 12%
28. Interleukin-13 12%
29. Fungi 11%
30. Immunoglobulin E 11%
31. Interleukin-15 11%
32. Systematic Reviews 11%
33. Arachis 10%
34. Peanut Hypersensitivity 10%
35. Mast Cells 10%
36. Nose 10%
37. Colonic Neoplasms 9%
38. In Vitro Techniques 9%
39. dectin 1 9%
40. Immunologic Desensitization 9%
41. Anaphylaxis 9%
42. Skin 9%
43. Sino-Nasal Outcome Test 9%
44. Allergic Rhinitis 8%
45. Lymphocytes 8%
46. Nasal Polyps 8%
47. thymic stromal lymphopoietin 8%
48. Allergy and Immunology 8%
49. Helper-Inducer T-Lymphocytes 8%
50. Innate Immunity 8%
51. Therapeutics 7%
52. Interleukin-4 7%
53. Orthomyxoviridae 7%
54. Antibodies 7%
55. Polyps 7%
56. Genes 7%
57. Plasmodium chabaudi 7%
58. Macrophages 7%
59. Immunoglobulin G 7%
60. Parasites 7%
61. Epithelial Cells 7%
62. Eosinophil Major Basic Protein 7%
63. Neoplasm Metastasis 7%
64. Thymocytes 7%
65. Biological Products 6%
66. Peptide Hydrolases 6%
67. Malaria 6%
68. Mucous Membrane 6%
69. Infections 6%
70. Meta-Analysis 6%
71. Human Influenza 6%
72. Hypersensitivity 6%
73. Paragonimus westermani 6%
74. Adaptive Immunity 6%
75. Guidelines 6%
76. Interleukin-6 6%
77. Sputum 6%
78. Phenotype 6%
79. Adenosine Triphosphate 6%
80. Neutrophils 5%
81. Cell Proliferation 5%
82. Venoms 5%
83. Vaccination 5%
84. Granulocyte-Macrophage Colony-Stimulating Factor 5%
85. CD8 Antigens 5%
86. Viruses 5%
87. Bothrops 5%
88. T-Cell Antigen Receptor 5%
89. Eosinophil Granule Proteins 5%
90. Population 5%
91. Pneumonia 5%
92. Aspirin 5%
93. Langerhans Cells 5%
94. Antigen-Presenting Cells 5%
95. Hemagglutinins 5%
96. Bone Marrow 5%
97. Pathology 5%
98. Omalizumab 5%
99. Cancer-Associated Fibroblasts 5%